U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C9H9Cl2N3O
Molecular Weight 246.093
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GUANFACINE

SMILES

NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl

InChI

InChIKey=INJOMKTZOLKMBF-UHFFFAOYSA-N
InChI=1S/C9H9Cl2N3O/c10-6-2-1-3-7(11)5(6)4-8(15)14-9(12)13/h1-3H,4H2,(H4,12,13,14,15)

HIDE SMILES / InChI
Molecular Formula C9H9Cl2N3O
Molecular Weight 246.093
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:12:35 UTC 2023
Edited
by admin
on Fri Dec 15 15:12:35 UTC 2023
Record UNII
30OMY4G3MK
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
GUANFACINE
INN   MI   VANDF   WHO-DD  
INN  
Official Name English
N-AMIDINO-2-(2,6-DICHLOROPHENYL)ACETAMIDE
Systematic Name English
GUANFACINE [MI]
Common Name English
GUANFACINE [VANDF]
Common Name English
ESTULIC
Brand Name English
guanfacine [INN]
Common Name English
NSC-759121
Code English
BENZENEACETAMIDE, N-(AMINOIMINOMETHYL)-2,6-DICHLORO-
Systematic Name English
Guanfacine [WHO-DD]
Common Name English
Classification Tree Code System Code
NDF-RT N0000175554
Created by admin on Fri Dec 15 15:12:35 UTC 2023 , Edited by admin on Fri Dec 15 15:12:35 UTC 2023
FDA ORPHAN DRUG 124199
Created by admin on Fri Dec 15 15:12:35 UTC 2023 , Edited by admin on Fri Dec 15 15:12:35 UTC 2023
NDF-RT N0000009918
Created by admin on Fri Dec 15 15:12:35 UTC 2023 , Edited by admin on Fri Dec 15 15:12:35 UTC 2023
WHO-ATC C02AC02
Created by admin on Fri Dec 15 15:12:35 UTC 2023 , Edited by admin on Fri Dec 15 15:12:35 UTC 2023
NCI_THESAURUS C270
Created by admin on Fri Dec 15 15:12:35 UTC 2023 , Edited by admin on Fri Dec 15 15:12:35 UTC 2023
FDA ORPHAN DRUG 405313
Created by admin on Fri Dec 15 15:12:35 UTC 2023 , Edited by admin on Fri Dec 15 15:12:35 UTC 2023
WHO-VATC QC02AC02
Created by admin on Fri Dec 15 15:12:35 UTC 2023 , Edited by admin on Fri Dec 15 15:12:35 UTC 2023
LIVERTOX NBK548586
Created by admin on Fri Dec 15 15:12:35 UTC 2023 , Edited by admin on Fri Dec 15 15:12:35 UTC 2023
Code System Code Type Description
LACTMED
Guanfacine
Created by admin on Fri Dec 15 15:12:35 UTC 2023 , Edited by admin on Fri Dec 15 15:12:35 UTC 2023
PRIMARY
FDA UNII
30OMY4G3MK
Created by admin on Fri Dec 15 15:12:35 UTC 2023 , Edited by admin on Fri Dec 15 15:12:35 UTC 2023
PRIMARY
DAILYMED
30OMY4G3MK
Created by admin on Fri Dec 15 15:12:35 UTC 2023 , Edited by admin on Fri Dec 15 15:12:35 UTC 2023
PRIMARY
IUPHAR
522
Created by admin on Fri Dec 15 15:12:35 UTC 2023 , Edited by admin on Fri Dec 15 15:12:35 UTC 2023
PRIMARY
ChEMBL
CHEMBL862
Created by admin on Fri Dec 15 15:12:35 UTC 2023 , Edited by admin on Fri Dec 15 15:12:35 UTC 2023
PRIMARY
NSC
759121
Created by admin on Fri Dec 15 15:12:35 UTC 2023 , Edited by admin on Fri Dec 15 15:12:35 UTC 2023
PRIMARY
EPA CompTox
DTXSID9046944
Created by admin on Fri Dec 15 15:12:35 UTC 2023 , Edited by admin on Fri Dec 15 15:12:35 UTC 2023
PRIMARY
DRUG BANK
DB01018
Created by admin on Fri Dec 15 15:12:35 UTC 2023 , Edited by admin on Fri Dec 15 15:12:35 UTC 2023
PRIMARY
RXCUI
40114
Created by admin on Fri Dec 15 15:12:35 UTC 2023 , Edited by admin on Fri Dec 15 15:12:35 UTC 2023
PRIMARY RxNorm
CAS
29110-47-2
Created by admin on Fri Dec 15 15:12:35 UTC 2023 , Edited by admin on Fri Dec 15 15:12:35 UTC 2023
PRIMARY
MESH
D016316
Created by admin on Fri Dec 15 15:12:35 UTC 2023 , Edited by admin on Fri Dec 15 15:12:35 UTC 2023
PRIMARY
DRUG CENTRAL
1343
Created by admin on Fri Dec 15 15:12:35 UTC 2023 , Edited by admin on Fri Dec 15 15:12:35 UTC 2023
PRIMARY
MERCK INDEX
m5866
Created by admin on Fri Dec 15 15:12:35 UTC 2023 , Edited by admin on Fri Dec 15 15:12:35 UTC 2023
PRIMARY Merck Index
INN
3999
Created by admin on Fri Dec 15 15:12:35 UTC 2023 , Edited by admin on Fri Dec 15 15:12:35 UTC 2023
PRIMARY
ECHA (EC/EINECS)
249-442-8
Created by admin on Fri Dec 15 15:12:35 UTC 2023 , Edited by admin on Fri Dec 15 15:12:35 UTC 2023
PRIMARY
SMS_ID
100000084474
Created by admin on Fri Dec 15 15:12:35 UTC 2023 , Edited by admin on Fri Dec 15 15:12:35 UTC 2023
PRIMARY
EVMPD
SUB07985MIG
Created by admin on Fri Dec 15 15:12:35 UTC 2023 , Edited by admin on Fri Dec 15 15:12:35 UTC 2023
PRIMARY
PUBCHEM
3519
Created by admin on Fri Dec 15 15:12:35 UTC 2023 , Edited by admin on Fri Dec 15 15:12:35 UTC 2023
PRIMARY
NCI_THESAURUS
C61779
Created by admin on Fri Dec 15 15:12:35 UTC 2023 , Edited by admin on Fri Dec 15 15:12:35 UTC 2023
PRIMARY
WIKIPEDIA
GUANFACINE
Created by admin on Fri Dec 15 15:12:35 UTC 2023 , Edited by admin on Fri Dec 15 15:12:35 UTC 2023
PRIMARY
Related Record Type Details
Structure of GUANFACINE HYDROCHLORIDE
SALT/SOLVATE -> PARENT
ALPHA-2A ADRENERGIC RECEPTOR
TARGET -> AGONIST
SHORT-ACTING
PLASMA PROTEIN FRACTION (HUMAN)
BINDER->LIGAND
BINDING
Related Record Type Details
Structure of ETIGUANFACINE
PRODRUG -> METABOLITE ACTIVE
Related Record Type Details
Structure of GUANFACINE
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Volume of Distribution PHARMACOKINETIC
Biological Half-life PHARMACOKINETIC
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966